5. Microbiology
âCoxsackieviruses most common
âCoxsackie A&B
âRickettsial myocarditis
âScrub typhus,
âRocky Mountain spotted fever
âQ fever
âDiphtheritic myocarditis 2° toxin
âConduction abnormalities + CHF
âChagas Disease
âCHF + RBBB in Central or S. America
18. Prognosis
âMany resolve spontaneously
âCardiac function can progressively
deteriorate
âMay evolve into dilated cardiomyopathy
âMolecular biology techniques suggest
idiopathic dilated cardiomyopathy may
represent end stage of viral myocarditis
21. Lyme Dz- Stg 1 early localized
âErythema migrans
â1 week post tick bite (range, 3-30 days)
âFlat or slightly raised red lesion at bite
âCommonly groin, thigh, or axilla
âLesion expands several dâs, with central clearing
â20% do not have typical skin lesions or lesions
unnoticed
âWithout Rx, erythema migrans resolve 3-4 wks
22. Lyme Stg 2- early
disseminated
âDays to weeks
â50% 2ndary lesions similar appearance primary
usually smaller
âHeadache & stiff neck + migratory pains in joints,
muscles, & tendons
âPersistent fatigue & malaise common
âNeurologic & musculoskeletal symptoms intermittent -
hours to day
âCardiac (4-10% of patients) - myocarditis, with
arrhythmias and heart block.
23. Case #3
â40 y/o Korean Female
âStg IV Breast Cancer
âAdriamycin Therapy total dose
âEchocardiogram
24. Drug-induced & Toxic Myocarditis
âDoxorubicin & other chemotherapy cytotoxic agents
âEmetine (an antiparasitic agent for amebiasis)
âCatecholamines (especially with pheochromocytoma)
âPhenothiazines, lithium, chloroquine, disopyramide,
antimony-containing compounds, and arsenicals
âHypersensitivity reactions sulfonamides, penicillins,
and aminosalicylic acid
âRadiation acute inflammatory reaction & chronic
fibrosis,
âUsually with pericarditis
25. Hypersensitivity Myocarditis
âChest discomfort, dyspnea, palpatations
âElevated JVP, Gallop Rythmn
âSinus Tach, ST segment changes, BBB,
AV Block, Vtach
âIncr CK-MB, Cardiomegaly
âEosinophils, atypical lymphs, giant cells
in BX
30. Case #4
â27 y/o Caucasian Male
âEpisoidic severe headache, palpitations, tachycardia,
profuse sweating, abdominal pain
âIncr nervousness & irritability, incr appetite, & loss of
weight.
âPostural tachycardia (change of more than 20
beats/min) & postural hypotension.
âPulmonary edema on CXR
31. Cocaine cardiotoxicity
âMarked Increase in incidence
âCoronary artery spasm, myocardial infarction,
arrhythmias, & myocarditis
âMediated by inhibitory effect on norepinephrine
reuptake by sympathetic nerves
âBeta-blockers have been used therapeutically
âCoronary spasm, Ca++ channel blockers
32. Protein-Calorie Malnultrition
âVacuolar degeneration of myofibrils
âEsp in conducting tissue
âSudden death common, possibly from
arrythmia
âDuring recovery findings of CHF often seen
âMalnourished children sensitive to digoxin,
use diuretic only
33. Beriberi Heart Disease
âThiamine deficiency 2° ingesting highly milled
rice as staple food
âAlso occurs in chronic alcoholism
âPeripheral vasodilatation - high output state
âReduced renal blood flow with retention of
Na+ & water
âIncreased blood volume & biventricular failure
34. Beriberi - diagnostic criteria
âHx/O Thiamine Deficiency
âExclusion of other causes of heart disease
âHigh output failure
âEvidence of peripheral neuritis or pellagra
âRapid response to therapeutic trial of
Thiamine
36. Alcoholic Cardiomyopathy
âMore common in men 30-55
âHeavy consumption of alcohol > 10yrs
âOften without liver disease or social
dysfunction
âPAF often initial presentation
âRX- IMMEDIATE & COMPLETE
ABSTINENCE
38. Septic Shock
âAcute mod to severe biventricular failure
âPreserved Atrial dimensions
âNO MR or TR
âTumor Necrosis Factor directly
Cardiotoxic
âReversible
39. Case #5
â44 y/o caucasian male pilot
âSustained asymptomatic Vtach @ pk
exercise
âRV enlargement + focal Apical RV
dyskinesia
âAbnormal MRI
40. Arrhythmogenic RV Dysplasia
âThinning & fatty infiltration of RV myocardium
(+-) fibrosis
âVentricular arrythmias & sudden death
âTypical presentation young males with
symptoms during exercise
âVTach usually of LBB type
âConsider in family history of sudden death
41. DILATED CARDIOMYOPATHY- Essentials of
Diagnosis
âSymptoms & signs of heart failure.
âECG
âLow OR Increased QRS voltage
âNonspecific repolarization abnormalities
âIntraventricular conduction abnormalities
âX-ray => cardiomegaly
âEcho => LVdilation, thinning, & global
dysfunction
42. Symptoms & Signs
âSyms may develop gradually
âAsymptomatic cardiomegaly
âEKG abnormalities or ventricular ectopy
âInitial presentation can be severe biventricular
failure
âCardiomegaly
âS3 gallop rhythm
âMurmur of functional mitral regurgitation
43. Ischemic Cardiomyopathy
âMost COMMON form of dilated
Cardiomyopathy
âSegmental Wall Motion Abnormalities
ââStunnedâ vs âHibernatingâ Myocardium
âGROWTH MARKET in Cardiomyopathy
44. Case # 6
â32 y/o Caucasian female
âProgressive dyspnea
âExertional Syncope
âAbnormal EKG - LVH with strain
âECHO
45. Case #7
â40 y/o F-16 Fighter Pilot
âHx/o Abnml EKG with deep inverted
Twaves precordial leads
âAsymptomatic
âAbnml Thallium Treadmill test with
COMPLETE RI of APEX
âEchocardiogram & Cardiac MRI
46. HYPERTROPHIC CARDIOMYOPATHY
âDyspnea, chest pain, syncope
âBisferiens carotid pulse, sustained (triple
apical impulse), Loud S4, systolic EM
(incr by upright posture/valsalva)
âECG left ventricular hypertrophy
âEcho asymetric hypertrophy normal or
incr contractility & signs of dynamic
obstruction
47. Mechanics
âInappropriate--ie, unrelated to pressure or
volume overload--myocardial hypertrophy
âTends to impinge upon left ventricular cavity
âIVS disproportionately involved (asymmetric
septal hypertrophy)
âIn some cases hypertrophy localized to apex
âLV outflow tract narrowed during systole
48. Pathophysiology
âDynamic obstruction
âWorsened by increased myocardial contractility
âSympathetic stimulation
âdigoxin
âpostextrasystolic beat
âWorsened by factors that decrease left ventricular
filling
âValsalva's maneuver
âperipheral vasodilators
50. Treatment
âBeta-blockers
âDyspnea, angina, & arrhythmias respond 50%
âCalcium channel blockers, esp verapamil
âMyomectomy
âDual-chamber pacing may prevent progression
of hypertrophy & obstruction
âAmiodarone &, possibly, sotalol may be
valuable
51. Prognosis
âNatural history highly variable
âMany asymptomatic many years or for life.
âSudden death, especially during exercise, may
be initial event
âMost frequently associated with sudden death
in athletes
âGradually progressive symptom
âMay transition into dilated cardiomyopathy
52. Case #8
â84 y/o Hispanic male
â6 mo hx/o dramatic decrease in
functional status
âMarked bilat effussions
âEchocardiogram
53. RESTRICTIVE CARDIOMYOPATHY
â Impaired diastolic filling with preserved contractile function
â Relatively uncommon
â Amyloidosis
â Radiation
â Myocardial fibrosis after open heart surgery
â In Africa, endomyocardial fibrosis, common
â Severe fibrosis of the endocardium
â Often with eosinophilia (Loffler's syndrome)
â Other causes
â Infiltrative cardiomyopathies (eg, sarcoidosis,
hemochromatosis, carcinoid syndrome)
54. Amyloidosis
âFrequent cause of restrictive cardiomyopathy
âMore frequently dilated cardiomyopathy with
congestive heart failure
âAlmost invariably conduction disturbances
âRectal, abdominal fat, or gingival biopsies or
myocardial biopsy
55. Primary Diagnostic Problem
âRestrictive cardiomyopathy vs constrictive pericarditis
âStatus of left ventricular function - helpful
âUsually normal with pericarditis + thickened
pericardium
âSlightly depressed with restrictive cardiomyopathy
âMyocardial biopsies usually negative with pericarditis
âIn some cases, only surgical exploration can make
diagnosis
â Connective tissue diseases (eg, scleroderma)
56. Unfortunately
âLittle useful therapy available for
causative conditions
âOR restrictive cardiomyopathy
âDiuretics can help
âExcessive diuresis can produce
worsening symptoms
57. Case # 9
â35 y/o active duty navigator
âTransfered for AICD placement
âFH (+) sudden death
âFerritin Level = 2500
58. Hemochromatosis
âAutosomal recessive disease with linkage to
HLA-A3 & HLA-B14 or HLA-A3 and HLA-B7
âHemosiderin in liver, pancreas, heart,
adrenals, testes, pituitary, & kidneys
âHepatic, pancreatic, & cardiac insufficiency
âDiabetes + Hypogonadism =>
Hemochromatosis
âRarely recognized before fifth decade
59. Case #10
â44 y/o black male
âAtrial Fibrillation with bradycardia rate
=45 bpm
â(+) Gallium scan (parotid uptake)
61. Case # 11
â74 y/o caucasian male with progressive
LE edema
âIncreasing dyspnea
âPersistent Eosinophlia = 40%
âEcho obliteration of apex
62. Loffler Endocarditis
âTypically male 4th or 5th decade of life
âBiventricular cardiac involvement is the rule
âMust differentiate Cuhurg-Strauss syndrome
(asthma, nasal-polyposis, necrotizing
vasculitis)
âDeath due to CHF although embolism can
occur
âCorticosteroids are Rx
âRoutine CHF Rx
64. Tropical Endomyocardial Fibrosis-
Epidemiology
âIn Uganda - as common a cause of
cardiac failure as RHD
âUganda - seen in 25% of cardiac
necropsies
âMore common in poorer socioeconomic
conditions
âIn endemic areas 50% occur in persons
< 15 yrs of age
66. Tropical Endomyocardial Fibrosis-
Pathology
âFibrosis of mural endocardium
âThrombus deposition followed by fibrotic
organization
âEarly in disease embolization may occur
âUsual extends to the mitral and tricuspid
valve apparatus
67. Tropical Endomyocardial Fibrosis-
Pathology
âValvular regurgitation can often occur
âRestriction of cardiac filling/cardiac output
âR-ventricle infundibulum hypertrophied and
dilated
âSevere R-sided failure symptoms can be
seen (ascites/hepatomegaly)
âL-ventricular involvement results in MR &
PAH
68. Tropical Endomyocardial Fibrosis- Clinical
Findings
âMay manifest in first several months in
life
âUsually recognized in advanced stages
âSymptoms advance rapidly
âProcess is usually biventricular
âHigh venous pressure causes
exopthalmos, periorbital facial edema,
74. Systolic Function
âContractile state of the myocardium
âPreload of the ventricle
âEnd-diastolic volume
âFiber length of ventricles
âPrior to onset of the contraction)
âAfterload (impedance to left ventricular
ejection)
âHeart rate
76. High Output Failure
âPump function supranormal but inadequate
âIncr metabolic demands
âIncr requirements blood flow
âCauses of high output failure
âThyrotoxicosis
âBberiberi
âSevere anemia
âArteriovenous shunting
âPaget's disease of bone
77. Diastolic Dysfunction
âFilling of the left or right ventricle is impaired
âChamber is noncompliant ("stiff")
âExcessive hypertrophy
âAbnormal myocardium
âContractility preserved
âDiastolic pressures elevated
âOccassionally cardiac output reduced
82. Hemodynamic Alterations
âMyocardial failure due to two
hemodynamic derangements
âClinical presentation determined by
severity of each
â1° reduction in C.O. or cardiac reserve
â2° incr ventricular diastolic pressures
âResult of compensatory processes
83. Right-sided vs Left-sided
â Left heart failure
â Low cardiac output & incr pulmonary venous pressure
â Dyspnea predominant sym
â Right heart failure
â Fluid retention predominates
â Edema, hepatic congestion, & occassionally ascites
â Most exhibit R- & L-sided failure
â LV dysfunction is most common cause RV failure
â Occ severe LV dysfunction simulates isolated right heart failure
â May be clinically indistinguishable from cor pulmonale
84. Diastolic Failure
â Diastolic dysfunction => symptoms systolic dysfxn
â Difficult to distinguish clinically
â Diastolic pressures incr with normal or low diastolic volumes
â Pressures transmitted to pulmonary & systemic venous systems
â Dyspnea & edema
â Most frequent cause LVH
â Hypertension
â Hypertrophic or restrictive cardiomyopathy
â Diabetes
â Pericardial disease
â Ischemia
â Diuretics useful other systolic therapies inappropriate